Global Submucosal Injections Market Research Report 2024

Publication ID:

PB506245717

Publication Date:

June 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The submucosal injections are required principally during the endoscopic mucosal resection techniques.They are an indispensable part of endoscopic submucosal dissection.听The most common submucosal injections were glucose water, hydroxypropyl methyl cellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.
The global Submucosal Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Submucosal injection is commonly used in medical and surgical procedures to achieve diagnosis, treatment, or relief. The increase in the incidence rate of cancer, the surge in the number of endoscopic mucosal resection, the increase in favorable reimbursement policies, and the development of the healthcare sector are the main drivers of global market growth.
This report aims to provide a comprehensive presentation of the global market for Submucosal Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injections.
Report Scope
The Submucosal Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Submucosal Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Submucosal Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus
Segment by Type
Syringe Type
Ampoules Type
Segment by Application
Hospital
Outpatient Surgery Center
Specialized Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Submucosal Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Submucosal Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Submucosal Injections Market Overview
1.1 Product Overview and Scope of Submucosal Injections
1.2 Submucosal Injections Segment by Type
1.2.1 Global Submucosal Injections Market Value Comparison by Type (2024-2030)
1.2.2 Syringe Type
1.2.3 Ampoules Type
1.3 Submucosal Injections Segment by Application
1.3.1 Global Submucosal Injections Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Outpatient Surgery Center
1.3.4 Specialized Clinics
1.4 Global Submucosal Injections Market Size Estimates and Forecasts
1.4.1 Global Submucosal Injections Revenue 2019-2030
1.4.2 Global Submucosal Injections Sales 2019-2030
1.4.3 Global Submucosal Injections Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Submucosal Injections Market Competition by Manufacturers
2.1 Global Submucosal Injections Sales Market Share by Manufacturers (2019-2024)
2.2 Global Submucosal Injections Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Submucosal Injections Average Price by Manufacturers (2019-2024)
2.4 Global Submucosal Injections Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Submucosal Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Submucosal Injections, Product Type & Application
2.7 Submucosal Injections Market Competitive Situation and Trends
2.7.1 Submucosal Injections Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Submucosal Injections Players Market Share by Revenue
2.7.3 Global Submucosal Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Submucosal Injections Retrospective Market Scenario by Region
3.1 Global Submucosal Injections Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Submucosal Injections Global Submucosal Injections Sales by Region: 2019-2030
3.2.1 Global Submucosal Injections Sales by Region: 2019-2024
3.2.2 Global Submucosal Injections Sales by Region: 2025-2030
3.3 Global Submucosal Injections Global Submucosal Injections Revenue by Region: 2019-2030
3.3.1 Global Submucosal Injections Revenue by Region: 2019-2024
3.3.2 Global Submucosal Injections Revenue by Region: 2025-2030
3.4 North America Submucosal Injections Market Facts & Figures by Country
3.4.1 North America Submucosal Injections Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Submucosal Injections Sales by Country (2019-2030)
3.4.3 North America Submucosal Injections Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Submucosal Injections Market Facts & Figures by Country
3.5.1 Europe Submucosal Injections Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Submucosal Injections Sales by Country (2019-2030)
3.5.3 Europe Submucosal Injections Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Submucosal Injections Market Facts & Figures by Country
3.6.1 Asia Pacific Submucosal Injections Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Submucosal Injections Sales by Country (2019-2030)
3.6.3 Asia Pacific Submucosal Injections Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Submucosal Injections Market Facts & Figures by Country
3.7.1 Latin America Submucosal Injections Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Submucosal Injections Sales by Country (2019-2030)
3.7.3 Latin America Submucosal Injections Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Submucosal Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Submucosal Injections Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Submucosal Injections Sales by Country (2019-2030)
3.8.3 Middle East and Africa Submucosal Injections Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Submucosal Injections Sales by Type (2019-2030)
4.1.1 Global Submucosal Injections Sales by Type (2019-2024)
4.1.2 Global Submucosal Injections Sales by Type (2025-2030)
4.1.3 Global Submucosal Injections Sales Market Share by Type (2019-2030)
4.2 Global Submucosal Injections Revenue by Type (2019-2030)
4.2.1 Global Submucosal Injections Revenue by Type (2019-2024)
4.2.2 Global Submucosal Injections Revenue by Type (2025-2030)
4.2.3 Global Submucosal Injections Revenue Market Share by Type (2019-2030)
4.3 Global Submucosal Injections Price by Type (2019-2030)
5 Segment by Application
5.1 Global Submucosal Injections Sales by Application (2019-2030)
5.1.1 Global Submucosal Injections Sales by Application (2019-2024)
5.1.2 Global Submucosal Injections Sales by Application (2025-2030)
5.1.3 Global Submucosal Injections Sales Market Share by Application (2019-2030)
5.2 Global Submucosal Injections Revenue by Application (2019-2030)
5.2.1 Global Submucosal Injections Revenue by Application (2019-2024)
5.2.2 Global Submucosal Injections Revenue by Application (2025-2030)
5.2.3 Global Submucosal Injections Revenue Market Share by Application (2019-2030)
5.3 Global Submucosal Injections Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Seikagaku
6.1.1 Seikagaku Corporation Information
6.1.2 Seikagaku Description and Business Overview
6.1.3 Seikagaku Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Seikagaku Submucosal Injections Product Portfolio
6.1.5 Seikagaku Recent Developments/Updates
6.2 Ovesco Endoscopy
6.2.1 Ovesco Endoscopy Corporation Information
6.2.2 Ovesco Endoscopy Description and Business Overview
6.2.3 Ovesco Endoscopy Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ovesco Endoscopy Submucosal Injections Product Portfolio
6.2.5 Ovesco Endoscopy Recent Developments/Updates
6.3 GI Supply
6.3.1 GI Supply Corporation Information
6.3.2 GI Supply Description and Business Overview
6.3.3 GI Supply Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GI Supply Submucosal Injections Product Portfolio
6.3.5 GI Supply Recent Developments/Updates
6.4 Cosmo Pharmaceuticals
6.4.1 Cosmo Pharmaceuticals Corporation Information
6.4.2 Cosmo Pharmaceuticals Description and Business Overview
6.4.3 Cosmo Pharmaceuticals Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cosmo Pharmaceuticals Submucosal Injections Product Portfolio
6.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boston Scientific Submucosal Injections Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 The Standard
6.6.1 The Standard Corporation Information
6.6.2 The Standard Description and Business Overview
6.6.3 The Standard Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.6.4 The Standard Submucosal Injections Product Portfolio
6.6.5 The Standard Recent Developments/Updates
6.7 Micro-Tech Endoscopy
6.6.1 Micro-Tech Endoscopy Corporation Information
6.6.2 Micro-Tech Endoscopy Description and Business Overview
6.6.3 Micro-Tech Endoscopy Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Micro-Tech Endoscopy Submucosal Injections Product Portfolio
6.7.5 Micro-Tech Endoscopy Recent Developments/Updates
6.8 EndoClot Plus
6.8.1 EndoClot Plus Corporation Information
6.8.2 EndoClot Plus Description and Business Overview
6.8.3 EndoClot Plus Submucosal Injections Sales, Revenue and Gross Margin (2019-2024)
6.8.4 EndoClot Plus Submucosal Injections Product Portfolio
6.8.5 EndoClot Plus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Submucosal Injections Industry Chain Analysis
7.2 Submucosal Injections Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Submucosal Injections Production Mode & Process
7.4 Submucosal Injections Sales and Marketing
7.4.1 Submucosal Injections Sales Channels
7.4.2 Submucosal Injections Distributors
7.5 Submucosal Injections Customers
8 Submucosal Injections Market Dynamics
8.1 Submucosal Injections Industry Trends
8.2 Submucosal Injections Market Drivers
8.3 Submucosal Injections Market Challenges
8.4 Submucosal Injections Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂